z-logo
open-access-imgOpen Access
Consequences of Disclosing Clinical Trial Results: Evidence from the Food and Drug Administration Amendments Act
Author(s) -
Thomas Bourveau,
Vedran Čapkun,
Yin Wang
Publication year - 2020
Publication title -
ssrn electronic journal
Language(s) - English
Resource type - Journals
ISSN - 1556-5068
DOI - 10.2139/ssrn.3533305
Subject(s) - food and drug administration , complaint , business , product (mathematics) , capital (architecture) , information asymmetry , drug , finance , medicine , pharmacology , law , political science , risk analysis (engineering) , geometry , mathematics , archaeology , history

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom